Heart Failure POC & LOC Devices Market: Market Analysis and Industry Insights 2024-2032
The Heart Failure POC & LOC Devices Market was valued at USD 128.4 million in 2023 and is projected to reach USD 292.8 million by 2031, growing at a compound annual growth rate (CAGR) of 10.7% during the forecast period 2024-2031. This surge reflects the increasing demand for advanced diagnostic tools in the management of heart failure. The keyword for this market is Heart Failure POC & LOC Devices Size, highlighting its role in transforming rapid and point-of-care diagnostics.
With rising incidences of cardiovascular conditions globally and a growing elderly population, the need for efficient, quick, and non-invasive diagnostic solutions is expanding. POC (Point-of-Care) and LOC (Lab-on-Chip) devices offer immediate results, facilitating faster clinical decisions and improved patient outcomes. Additionally, technological innovations and miniaturization in diagnostic platforms are driving broader adoption in hospitals, clinics, and homecare settings.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/2565
Key Players
1. Abbott
2. Danaher Corporation
3. Siemens Healthineers
4. F. Hoffmann-La Roche Ltd.
5. Quidel Corporation
6. bioMérieux S.A.
7. Trinity Biotech
8. Instrumentation Laboratory
9. Abaxis, Inc.
10. Becton, Dickinson and Company
11. BioTelemetry, Inc.
12. Masimo Corporation
13. Novartis AG
14. Stryker Corporation
Key Points:
- Market valuation expected to surpass USD 292.8 million by 2031.
- Projected CAGR of 10.7% from 2024 to 2031.
- Rising heart failure cases fueling demand for POC and LOC devices.
- Increasing integration of microfluidic technology enhances device efficiency.
- Growing preference for home-based monitoring and diagnostic solutions.
- North America holds a leading share due to advanced healthcare infrastructure.
Future Scope:
As healthcare systems globally shift towards value-based and patient-centric models, the market for Heart Failure POC & LOC Devices is set to experience sustained growth. Emerging economies are gradually embracing these diagnostic innovations, supported by investments in healthcare technology and infrastructure. Further advancements in biosensor design, wireless data transmission, and AI integration are expected to redefine how heart failure is diagnosed and managed at the point of care.
Conclusion:
The Heart Failure POC & LOC Devices Market is witnessing dynamic growth, driven by the urgent need for rapid, reliable, and accessible diagnostic solutions. As the burden of heart failure continues to mount, these technologies are poised to play a pivotal role in modern healthcare delivery, offering timely intervention and improved patient care outcomes.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
Comments
0 comment